Zile Shen

Dr. Zile Shen

Tongji University, Shanghai, China
+1
orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2022 in Free Radical Biology and Medicine
Verified
Journal Article
Closed access
XYXialin Yan
Xialin Yan
ZSZile Shen
Zile Shen
DYDingye Yu
Dingye Yu
CZChong-Ke Zhao
Chong-Ke Zhao
HZHongbo Zou
Hongbo Zou
ZYZhen Yu
Zhen Yu

20 July 2022 in Surgery
Verified
Journal Article
Closed access
WCWei-Zhe Chen
Wei-Zhe Chen
ZSZile Shen
Zile Shen
FZFeng-Min Zhang
Feng-Min Zhang
XZXian-Zhong Zhang
Xian-Zhong Zhang
WCWen-Hao Chen
Wen-Hao Chen
ZYZhen Yu
Zhen Yu

24 November 2022 in Oxidative Medicine and Cellular Longevity
Verified
Journal Article
Open access
PDF file
WDWenxi Dong
Wenxi Dong
WCWenhao Chen
Wenhao Chen
HZHongbo Zou
Hongbo Zou
ZSZile Shen
Zile Shen
DYDingye Yu
Dingye Yu
ZYZhen Yu
Zhen Yu
Sarcopenia, featured by the progressive loss of skeletal muscle function and mass, is associated with the impaired function of muscle stem cells (MuSCs) caused by increasing oxidative stress in senescent skeletal muscle tissue during aging. Intact function of MuSCs maintains the regenerative potential as well as the homeostasis of skeletal muscle tissues during aging. Ginsenoside Rb1, a natural compound from ginseng, exhibited the effects of antioxidation and against apoptosis. However, its effects of restoring MuSC function during aging and improving age‐related sarcopenia remained unknown. In this study, we investigated the role of Rb1 in improving MuSC function and inhibiting apoptosis by reducing oxidative stress levels. We found that Rb1 inhibited the accumulation of reactive oxygen species (ROS) and protected the cells from oxidative stress to attenuate the H2O2‐induced cytotoxicity. Rb1 also blocked oxidative stress‐induced apoptosis by inhibiting the activation of caspase‐3/9, which antagonized the decrease in mitochondrial content and the increase in mitochondrial abnormalities caused by oxidative stress via promoting the protein expression of genes involved in mitochondrial biogenesis. Mechanistically, it was proven that Rb1 exerted its antioxidant effects and avoided the apoptosis of myoblasts by targeting the core regulator of the nuclear factor‐kappa B (NF‐κB) signal pathway. Therefore, these findings suggest that Rb1 may have a beneficial role in the prevention and treatment of MuSC exhaustion‐related diseases like sarcopenia.

1 August 2021 in European Journal of Surgical Oncology
Verified
Journal Article
Closed access
HZHong-Bo Zou
Hong-Bo Zou
XYXia-Lin Yan
Xia-Lin Yan
WDWen-Xi Dong
Wen-Xi Dong
DYDing-Ye Yu
Ding-Ye Yu
FZFeng-Min Zhang
Feng-Min Zhang
ZYZhen Yu
Zhen Yu

1 April 2021 in Nutrition
Verified
Journal Article
Closed access
LZLi-Ping Zhou
Li-Ping Zhou
DYDing-Ye Yu
Ding-Ye Yu
BMBing-Wei Ma
Bing-Wei Ma
ZSZile Shen
Zile Shen
HZHong-Bo Zou
Hong-Bo Zou
ZYZhen Yu
Zhen Yu

9 April 2022 in Asian Journal of Surgery
Verified
Journal Article
Open access
ZSZile Shen
Zile Shen
ZLZhang Liu
Zhang Liu
WZWang-Fu Zang
Wang-Fu Zang
PZPeng Zhang
Peng Zhang
HZHong-Bo Zou
Hong-Bo Zou
ZYZhen Yu
Zhen Yu
The relationship between thoracic sarcopenia and clinical outcomes in patients underwent coronary artery bypass grafting (CABG) is unclear. This study aims to evaluate whether thoracic sarcopenia has a satisfactory prognostic effect on adverse outcomes after CABG. From December 2015 to May 2021, 338 patients who underwent isolated CABG at our institution were recruited in this study. Skeletal muscle area at T12 level acquired by chest computed tomography (CT) was normalized to assess thoracic sarcopenia. Univariate and multivariate analyses were performed to evaluate the risk factors of postoperative complications and overall survival (OS). The prevalence of thoracic sarcopenia in patients underwent CABG was 13.02%. The incidence of total major complication was significantly higher in thoracic sarcopenia group (81.8% vs 61.9%, p = 0.010). Thoracic sarcopenic patients also had longer postoperative hospital stays (p = 0.047), intensive care unit (ICU) stays (p = 0.001), higher costs (p = 0.001) and readmission rates within 30 days of discharge (18.2% vs 4.4%, p = 0.001). Patients without thoracic sarcopenia showed significantly higher OS at the 2-year follow-up period (93.9% vs 72.7%, p<0.001). Multivariate analyses demonstrated that thoracic sarcopenia was significantly and independently associated with postoperative complications and long-term OS after CABG. Thoracic sarcopenia is an effective clinical predictor of adverse postoperative complications and long-term OS in patients underwent CABG. Thoracic sarcopenia based on chest CT should be included in preoperative risk assessment of CABG.